Epidiolex ema approval date?

What was Epidiolex’s EMA approval date?

Epidiolex (cannabidiol) received European Medicines Agency (EMA) approval on 19 June 2018 for use in specific forms of epilepsy. [1]

Which conditions was Epidiolex approved for in the EU?

The EMA approval covered Epidiolex for treatment of:
- Dravet syndrome
- Lennox–Gastaut syndrome
both in patients aged 2 years and older, when seizures are associated with these syndromes. [1]

Source

1. DrugPatentWatch.com – Epidiolex (cannabidiol) EMA Approval